Cargando…
Elevated Expression of ASXL2 is Associated with Poor Prognosis in Colorectal Cancer by Enhancing Tumorigenesis and Inducing Cell Proliferation
OBJECTIVE: Colorectal cancer is one of the most common malignant tumors worldwide. ASXL2 is an enhancer of the trithorax and polycomb genes, which have been proven to act in many tumor types. The role of ASXL2 in the occurrence and development of tumors has been extensively studied in recent years....
Autores principales: | Cui, Ran, Yang, Ludi, Wang, Yiwei, Zhong, Ming, Yu, Minhao, Chen, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585280/ https://www.ncbi.nlm.nih.gov/pubmed/33116876 http://dx.doi.org/10.2147/CMAR.S266083 |
Ejemplares similares
-
Identification of Candidate Biomarker ASXL2 and Its Predictive Value in Pancreatic Carcinoma
por: Wang, Gaoming, et al.
Publicado: (2021) -
High levels of SIRT1 expression enhance tumorigenesis and associate with a poor prognosis of colorectal carcinoma patients
por: Chen, Xiaojing, et al.
Publicado: (2014) -
Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases
por: Gelsi-Boyer, Véronique, et al.
Publicado: (2012) -
Elevated expression of CXCL16 correlates with poor prognosis in patients with colorectal cancer
por: Chen, Zhihui, et al.
Publicado: (2019) -
Elevated OCT1 participates in colon tumorigenesis and independently predicts poor prognoses of colorectal cancer patients
por: Wang, Yu-peng, et al.
Publicado: (2015)